PCM
JAZZ icon

Poehling Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Poehling Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.28M Sell
21,892
-747
-3% -$164K 1.13% 26
2026
Q1 		$4.28M Sell
22,639
-50
-0.2% -$8.74K 0.9% 38
2025
Q4 		$3.86M Sell
22,689
-328
-1% -$50.3K 0.79% 40
2025
Q3 		$3.03M Sell
23,017
-328
-1% -$39.3K 0.64% 44
2025
Q2 		$2.48M Buy
23,345
+527
+2% +$57.2K 0.58% 49
2025
Q1 		$2.83M Sell
22,818
-164
-0.7% -$21.4K 0.72% 45
2024
Q4 		$2.83M Buy
22,982
+11
+0% +$1.3K 0.7% 43
2024
Q3 		$2.56M Buy
22,971
+1,280
+6% +$140K 0.65% 50
2024
Q2 		$2.32M Buy
21,691
+805
+4% +$88.5K 0.63% 48
2024
Q1 		$2.52M Buy
20,886
+2,170
+12% +$266K 0.67% 45
2023
Q4 		$2.3M Buy
18,716
+11,952
+177% +$1.49M 0.73% 46
2023
Q3 		$876K Sell
6,764
-609
-8% -$81.1K 0.31% 69
2023
Q2 		$914K Buy
+7,373
New +$992K 0.31% 72
2022
Q3 		– Sell
-8,343
Closed -$1.3M – 120
2022
Q2 		$1.3M Sell
8,343
-210
-2% -$32.3K 0.49% 53
2022
Q1 		$1.33M Sell
8,553
-3,237
-27% -$470K 0.41% 62
2021
Q4 		$1.5M Buy
11,790
+728
+7% +$95.7K 0.48% 60
2021
Q3 		$1.44M Buy
+11,062
New +$1.67M 0.49% 62

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Poehling Capital Management's JAZZ Position: Q2 2026 in Review

Poehling Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 3.3% in Q2 2026, selling an estimated $164K and leaving 21,892 shares worth $5.28M. The position accounts for 1.13% of the portfolio, ranked #26.

Poehling Capital Management first reported a position in JAZZ in Q3 2021 and has held it in 17 quarters since. 237 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Poehling Capital Management held 21,892 shares of Jazz Pharmaceuticals worth $5.28M as of Q2 2026.
  • Poehling Capital Management sold 747 Jazz Pharmaceuticals shares in Q2 2026, an estimated $164K.
  • Jazz Pharmaceuticals made up 1.13% of Poehling Capital Management's portfolio in Q2 2026, its #26 holding.
  • Poehling Capital Management first reported a position in Jazz Pharmaceuticals in Q3 2021 and has held it in 17 quarters since.
  • 237 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Poehling Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.